Genome-wide interaction study of brain beta-amyloid burden and cognitive impairment in Alzheimer’s disease
Aristotle N. Voineskos(Centre for Addiction and Mental Health), Bruce G. Pollock(Centre for Addiction and Mental Health), David A. Bennett(Rush University Medical Center), Arash Nazeri, Tina Roostaei(Columbia University Irving Medical Center), Philip L. De Jager(Broad Institute), Daniel Felsky(Centre for Addiction and Mental Health), Julie A. Schneider(University of California San Diego)
Cited by 71
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|7.1k
National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease
|Alzheimer s & Dementia|2012|3.2k
National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach
|Acta Neuropathologica|2011|2.9k
Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature
|Journal of Neuropathology & Experimental Neurology|2012|2.1k